11 February 2021
Maxwellia announces appointment of Tim Holmes as Head of Sales
Maxwellia, the UK’s only dedicated expert medicines switching company, has appointed Tim Holmes to the newly created role of Head of Sales with responsibility for building the company’s customer strategy and customer success model. The appointment is the second so far in 2021 and reflects the company’s rapid expansion over the past 12 months and comes as Maxwellia is poised to create a major step-change in women’s health with the launch of a much-awaited new product.
Tim brings over 25 years of UK and global commercial experience gained working with high profile consumer brands such as Durex and Scholl, along with a wide range of OTC Medicines and Medical Devices. He has strong track record of building businesses and establishing brands in challenging and new markets. Tim joins Maxwellia from Crawford Healthcare where, as Commercial Director, he drove a fourfold increase in turnover over six years, expanding into multiple new markets and launching a large range of new products.
Maxwellia founder and CEO, Anna Maxwell says: “2021 is going to be a very exciting year for Maxwellia as we bring our new product to market and we are delighted to have Tim on board. He brings with him a wealth of knowledge and expertise and importantly he also shares our vision of widening access to medicines through pharmacy and his experience and talent will further support our company as we enter a very exciting new phase of growth”.